Abbinanti v. Presence Central and Suburban Hospitals Network

2021 IL App (2d) 210763, 191 N.E.3d 1265, 455 Ill. Dec. 557
CourtAppellate Court of Illinois
DecidedDecember 29, 2021
Docket2-21-0763
StatusPublished
Cited by3 cases

This text of 2021 IL App (2d) 210763 (Abbinanti v. Presence Central and Suburban Hospitals Network) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abbinanti v. Presence Central and Suburban Hospitals Network, 2021 IL App (2d) 210763, 191 N.E.3d 1265, 455 Ill. Dec. 557 (Ill. Ct. App. 2021).

Opinion

2021 IL App (2d) 210763 No. 2-21-0763 Opinion filed December 29, 2021 ______________________________________________________________________________

IN THE

APPELLATE COURT OF ILLINOIS

SECOND DISTRICT ______________________________________________________________________________

MICHAEL ABBINANTI, as Health Care ) Appeal from the Circuit Court Agent for Sebastian Abbinanti, and LUISA ) of Kane County. FASO, as Health Care Agent for Maria ) Abbinanti, ) ) Plaintiffs-Appellants, ) ) v. ) No. 21-MR-2143 ) PRESENCE CENTRAL AND ) SUBURBAN HOSPITALS NETWORK, ) d/b/a Amita Health Saint Joseph Hospital ) Elgin, ) Honorable ) Robert J. Villa, Defendant-Appellee. ) Judge, Presiding. ______________________________________________________________________________

JUSTICE SCHOSTOK delivered the judgment of the court, with opinion. Justices Jorgensen and Birkett concurred in the judgment and opinion.

OPINION

¶1 The facts underlying this case are sad indeed. Sebastian and Maria Abbinanti, the 40-year-

old parents of three children, were admitted to the intensive care unit (ICU) of Amita Health Saint

Joseph Hospital Elgin (Saint Joseph or hospital) with COVID-19 in late November 2021. Despite

receiving every treatment permitted under the hospital’s protocols, they remained critically ill.1

1 Just how ill the Abbinantis were was confirmed in the saddest possible way when, during 2021 IL App (2d) 210763

On December 15, 2021, their representatives—the plaintiffs, Michael Abbinanti, as health care

agent for Sebastian Abbinanti, and Luisa Faso, as health care agent for Maria Abbinanti— filed an

emergency motion in the circuit court, seeking an immediate mandatory injunction (a temporary

restraining order or TRO) requiring the hospital to administer the medication ivermectin to them.

The parties filed briefs and supporting materials, and after a lengthy hearing on December 17, the

trial court denied the request for a TRO. The plaintiffs filed this expedited appeal. We affirm.

¶2 I. BACKGROUND

¶3 Ivermectin is approved for internal use in humans (and animals, albeit at different dosages)

to treat intestinal infections caused by some parasitic worms. It is also approved in a topical form

to treat head lice and certain skin conditions such as rosacea. Although some physicians have

recommended the use of ivermectin to treat COVID-19, the Food and Drug Administration (FDA)

has not approved such use, stating that “[c]urrently available data do not show ivermectin is

effective against COVID-19.” See Why You Should Not Use Ivermectin to Treat or Prevent

COVID-19, U.S. Food & Drug Admin. (Dec. 12, 2021), https;//www.fda.gov/consumers/consumer

-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 [https://perma.cc/VZM6-

DB49]. The American Medical Association (AMA), American Pharmacists Association (APA),

and American Society of Health-Systems Pharmacists (ASHSP) have issued a joint statement that

they “strongly oppose the ordering, prescribing, or dispensing of ivermectin to prevent or treat

COVID-19 outside of a clinical trial.” See AMA, APhA, ASHP Statement on Ending Use of

the brief pendency of this appeal, Maria Abbinanti passed away. Although the appeal is now moot

as to her, the issues raised on her behalf apply equally to her husband and are addressed by us

herein.

-2- 2021 IL App (2d) 210763

Ivermectin to Treat COVID-19, Am. Med. Ass’n (Sept. 1, 2021) https://www.ama-assn.org/press-

center/press-releases/ama-apha-ashp-statement-ending-use-ivermectin-treat-covid-19

[https://perma.cc/S4C6-3NZH]. The defendant, Presence Central and Suburban Hospitals

Network, owns and operates Saint Joseph. Aware of the rising public demand for ivermectin as a

treatment for COVID-19 as well as the cautions against such use by medical and governmental

bodies, the defendant undertook its own consideration of the issue. In September 2021, the

defendant adopted a policy prohibiting the administration of ivermectin to treat COVID-19 at its

hospitals, including at Saint Joseph.

¶4 Dr. Sergei Lipov is a doctor of internal medicine. In an unattested declaration submitted

with the plaintiffs’ complaint for declaratory and injunctive relief, Dr. Lipov stated that he was

“on staff” at the hospital and that he had been the attending physician for the Abbinantis during

their stay at Saint Joseph’s ICU. After all of the available protocols to treat the Abbinantis’

COVID-19 had been implemented without any improvement in their conditions, he asked to

administer ivermectin to them, as requested by their representatives. Dr. Lipov stated that he had

reviewed medical literature promoting such use and had weighed the possibility of adverse impact

on the Abbinantis from ivermectin. Without stating that he believed that ivermectin would be

effective to treat the Abbinantis’ COVID-19, he noted that their families were “desperate to help

them as much as possible” and said that he did “not see any harm in trying this drug even if only

to reassure family members that ‘everything possible’ was done to save” the Abbinantis. Because

of the defendant’s policy against such use of ivermectin, however, Dr. Lipov was unable to write

or fill a prescription for ivermectin or administer it to the Abbinantis in Saint Joseph’s ICU. The

plaintiffs then brought suit on behalf of the Abbinantis.

-3- 2021 IL App (2d) 210763

¶5 During the rapid briefing of the TRO motion, both sides presented materials regarding the

possible efficacy of ivermectin to treat or prevent COVID-19. The plaintiffs relied upon articles

and an unattested declaration by Pierre Kory, M.D., who identified himself as an expert on the

management of COVID-19 and in particular on the use of ivermectin to treat or prevent it. The

defendant presented reports critiquing the studies relied upon by Dr. Kory as small and not well-

designed, noting that no adequately sized and well-designed studies had observed any effect from

ivermectin, and noting an increase in adverse reactions and calls to poison-control centers

associated with the use of ivermectin.

¶6 The trial court reviewed all of the materials presented and heard argument from both sides.

It commented that, although Dr. Kory and the other physicians who supported the use of ivermectin

might be characterized as a “fringe” group, the court itself generally believed that new and

alternative medical approaches could be valid and that patients’ desires to avail themselves of such

approaches should be respected. However, the question before it was not whether treatment with

ivermectin was a good idea or a bad one, but whether the plaintiffs had made a valid legal case

that the court should override the hospital’s judgment about ivermectin. Thus, it was required to

focus on whether the plaintiffs had shown the requirements for a TRO: a protectible right,

irreparable harm, an inadequate remedy at law, and a likelihood of success on the merits.

¶7 Turning to those elements, the trial court found that the plaintiffs had not shown that the

Abbinantis had a legal right to be administered medication that was against the standard of care

developed by the hospital. The plaintiffs had argued that, as patients, the Abbinantis (and by

extension their representatives) had an express contract with the hospital pursuant to the hospital’s

written statement of “patient rights and responsibilities.” That document noted patients’ rights to,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re T.J.
2026 IL App (1st) 242406 (Appellate Court of Illinois, 2026)
360 Health MSO, LLC v. Hopkins
2026 IL App (5th) 260145-U (Appellate Court of Illinois, 2026)
Jefferson v. Chicago Housing Authority
2026 IL App (1st) 260279 (Appellate Court of Illinois, 2026)
Somen v. Amateur Hockey Ass'n of Illinois, Inc.
2024 IL App (2d) 240583-U (Appellate Court of Illinois, 2024)
In re Marriage of McDowell
2023 IL App (2d) 230081-U (Appellate Court of Illinois, 2023)
Allen Gahl v. Aurora Health Care, Inc.
Court of Appeals of Wisconsin, 2022

Cite This Page — Counsel Stack

Bluebook (online)
2021 IL App (2d) 210763, 191 N.E.3d 1265, 455 Ill. Dec. 557, Counsel Stack Legal Research, https://law.counselstack.com/opinion/abbinanti-v-presence-central-and-suburban-hospitals-network-illappct-2021.